Analystreport

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) was downgraded by analysts at TheStreet from a "b+" rating to a "c+" rating.

Supernus Pharmaceuticals, Inc.  (SUPN) 
Last supernus pharmaceuticals, inc. earnings: 2/25 04:40 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.supernus.com